Nexeon Medsystems (NXNN) & The Competition Head to Head Survey

Nexeon Medsystems (OTCMKTS: NXNN) is one of 46 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its competitors? We will compare Nexeon Medsystems to similar businesses based on the strength of its analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Earnings and Valuation

This table compares Nexeon Medsystems and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Nexeon Medsystems $3.30 million -$2.17 million -2.88
Nexeon Medsystems Competitors $1.11 billion $97.36 million -33.94

Nexeon Medsystems’ competitors have higher revenue and earnings than Nexeon Medsystems. Nexeon Medsystems is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

43.6% of shares of all “Electromedical equipment” companies are held by institutional investors. 61.2% of Nexeon Medsystems shares are held by company insiders. Comparatively, 18.2% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Nexeon Medsystems and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Nexeon Medsystems N/A N/A N/A
Nexeon Medsystems Competitors -169.18% -79.00% -19.73%

Analyst Recommendations

This is a summary of current ratings and target prices for Nexeon Medsystems and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nexeon Medsystems 0 1 0 0 2.00
Nexeon Medsystems Competitors 160 477 1010 36 2.55

As a group, “Electromedical equipment” companies have a potential upside of 8.55%. Given Nexeon Medsystems’ competitors stronger consensus rating and higher possible upside, analysts clearly believe Nexeon Medsystems has less favorable growth aspects than its competitors.

Summary

Nexeon Medsystems competitors beat Nexeon Medsystems on 7 of the 12 factors compared.

Nexeon Medsystems Company Profile

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply